News Delayed TED Underrecognized Following MS Treatment by Medscape • 2026/07/09 • 0 Comments Reports of cases detail the development of thyroid eye disease 3-5 years following treatment of MS with immunomodulatory therapy including alemtuzumab. Medscape Medical News